Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation.
about
Antiplatelet Therapy in Hemodialysis Patients Undergoing Percutaneous Coronary InterventionsStent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014Early Clinical Experience with a Polymer-Free Biolimus A9 Drug-Coated Stent in DES-Type Patients Who Are Poor Candidates for Prolonged Dual Anti-Platelet TherapyClinical impact of dual antiplatelet therapy use in patients following everolimus-eluting stent implantation: insights from the SEEDS study.Drug-eluting stents to prevent stent thrombosis and restenosis.Percutaneous coronary interventions and antiplatelet therapy in renal transplant recipients.Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: conceptual evolution based on emerging evidence.Is it time to take bare metal stents off the catheter laboratory shelf?Bioresorbable vascular scaffolds - basic concepts and clinical outcome.Comparison of Vascular Responses Following New-Generation Biodegradable and Durable Polymer-Based Drug-Eluting Stent Implantation in an Atherosclerotic Rabbit Iliac Artery Model.Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study.Early vascular healing after titanium-nitride-oxide-coated stent versus platinum-chromium everolimus-eluting stent implantation in patients with acute coronary syndrome.Incidence and prognosis of stent thrombosis following percutaneous coronary intervention in Middle Eastern patients: The First Jordanian Percutaneous Coronary Intervention Registry (JoPCR1).Clinical Outcome of First- vs Second-Generation DES According to DAPT Duration: Results of ARCTIC-Generation.Dual antiplatelet therapy for secondary prevention of coronary artery disease.Optimizing the duration of dual antiplatelet therapy after implantation of drug-eluting coronary stents.Comparative Long-Term Effect of Three Anti-P2Y12 Drugs after Percutaneous Angioplasty: An Observational Study Based on Electronic Drug Adherence Monitoring.Angiographic and clinical performance of polymer-free biolimus-eluting stent in patients with ST-segment elevation acute myocardial infarction in a metropolitan public hospital: The BESAMI MUCHO study.Rationale and design of amphilimus sirolimus-eluting stents versus zotarolimus-eluting stents in all-comers requiring percutaneous coronary intervention (ReCre8): A multicenter randomized clinical trial.[Focused update on dual antiplatelet treatment : ESC guidelines 2017].Angiographic predictors of 2-year stent thrombosis in patients receiving drug-eluting stents: Insights from the ADAPT-DES study.Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST-Elevation Myocardial Infarction.Neointimal coverage of zotarolimus-eluting stent at 1, 2, and 3 months' follow-up: an optical coherence tomography study.Optimal Duration of Dual Antiplatelet Therapy after Drug-Eluting Stents: Meta-Analysis of Randomized Trials.
P2860
Q26777116-E5230263-FED9-4195-95ED-813E8B2FAD06Q26785321-F3F1411B-55B9-4868-8B86-BBB26B1DCB30Q28552288-3A33EDF4-F09D-4F3A-AF56-BC9BEA1C008FQ36804729-1025A812-D38A-4792-8A7F-DBDC15CB425FQ38633332-55516F82-4BFB-4D1D-8D7B-4A927B99F88CQ38672873-D9E700DD-3EB3-4348-B0FD-8B97BF8E5D8FQ38706266-A5E7B460-62D4-43C6-BA79-7A9679D3DB04Q38860495-2EDE6CD4-C90D-4F11-9448-380031C0EAD8Q38967027-9D5CEFAD-674F-4555-9F34-076164969664Q39238408-C3FDBDFB-1B80-47D9-A478-298C4504E150Q39288609-ED4AF107-7F7D-4ED3-8D93-B5AD92A32FA6Q39852610-2EFCB1A1-1E58-46D6-966D-CCF1CA4F830FQ39963040-B32549E0-8973-433D-AA22-A929AA53965EQ40908174-B43CEBEB-CE68-4F2E-81C8-BF30E4D1FE57Q42650020-00CD9FAF-A73B-4C58-9E3C-FE356CCD1E24Q42877626-6143195E-9C80-4962-A43D-ADED2CCCB4B0Q46253334-42F27388-B854-40D2-9A57-34252BD6432BQ47853894-EEC1DD4F-A8C6-4833-BB68-14D14F28F66EQ48092260-2C677AD5-EC58-4216-A655-92389E45FE03Q50085963-28FB9165-8B4F-487E-A442-A647AD0D79B2Q51545745-2C932060-7EBF-4EEB-B369-BF42C0075D0CQ52589129-426B2EBB-3949-4B09-B790-0B9B24384AF5Q53399613-49EA9A34-CEDE-4BDB-9A43-B718DF8C78D1Q53492659-A4193FE0-42F7-4017-80BE-7BA6CDB8E6D9
P2860
Lack of association between dual antiplatelet therapy use and stent thrombosis between 1 and 12 months following resolute zotarolimus-eluting stent implantation.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Lack of association between du ...... us-eluting stent implantation.
@en
type
label
Lack of association between du ...... us-eluting stent implantation.
@en
prefLabel
Lack of association between du ...... us-eluting stent implantation.
@en
P2093
P2860
P356
P1476
Lack of association between du ...... us-eluting stent implantation.
@en
P2093
Jorge A Belardi
Martin Rothman
Minglei Liu
Sandeep Brar
Sigmund Silber
P2860
P304
P356
10.1093/EURHEARTJ/EHU026
P577
2014-02-07T00:00:00Z